乳腺癌年轻患者的放射治疗降级:我们还在那里吗?
Ioannis Georgakopoulos1, Georgios Nikiforos Ntoumas1, Pantelis Skarlos2
1Radiation Oncology Unit, 1st Department of Radiology, Medical School, Aretaieion Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Cancers
|February 27, 2026
概括
早期乳腺癌的放射治疗缓解需要小心,在年轻女性. 适度的低分化是安全的,但其他降级策略的证据在50岁以下的患者中是有限的.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- 放射治疗缓解是为早期乳腺癌确立的,但试验主要包括老年患者.
- 年轻女性患有乳腺癌的特征不那么有利,结果更糟糕,但在降级研究中代表性不足.
研究的目的:
- 系统地审查放射治疗缓和策略的安全性和实施,在早期被诊断为乳腺癌的年轻患者中.
主要方法:
- 一个符合PRISMA 2020的文献搜索发现了有关在年轻乳腺癌患者中减缓放射治疗的相关研究.
- 审查了流行病学数据,随机试验和临床指南,并补充了来自ClinicalTrials.gov.gov的信息.
主要成果:
- 较年轻的年龄与侵袭性瘤生物学,较高的结节参与,不利的亚型和较差的生存率相关.
- 适度的低分化 (15-16分) 得到证据和适用于所有年龄段的指导方针的支持.
- 在年轻人群中,对超低分离,部分乳房照射和放弃放射治疗的证据不那么强大.
结论:
- 在年轻的乳腺癌患者中,放缓放射治疗需要谨慎的做法.
- 适度的低分化是一种安全的选择,但积极的降级策略在50岁以下的女性中缺乏足够的证据.
- 需要对年轻患者进行充分代表的前性研究,以确定最佳的缓和策略.
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K


